Consumer group asks FDA to pull Alzheimer’s drug from market
May 20, 2011
By Rita R. Robison, Consumer Specialist A drug used to treat moderate or severe cases of Alzheimer’s disease should be removed from the market immediately because of its risk of serious adverse effects and its lack of effectiveness, Public Citizen and a geriatrician from Johns Hopkins said in a petition... Read more →